Precision’s specialty in vitro and ex vivo assays achieve a variety of research, safety, efficacy, and biomarker objectives to speed and streamline your research and clinical trials. Multiplatform immune monitoring solutions
support you from preclinical through phase 3 studies, supported by our global biorepository footprint, cell biology, sample processing, and molecular capabilities. Because you need high-quality, accurate study results, we deliver meticulous sample handling and sophisticated global logistics—always utilizing industry-leading quality systems, including GxP, ISO 9001, ISO 13485, College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA).
Advanced custom assays. We build our custom cell-based assays using cell lines or primary cells (both normal and patient-derived). We also deliver novel ligand-binding assay approaches for greater ease of validation and scalability. Our assays are run routinely to support preclinical and clinical studies.
Global biorepositories and biobanking. Precision manages 25 million + biospecimens—with samples from over 100 active clinical trials on 6 continents. We house samples in LN 2, at -80; -20; +4°C; and ambient temperature—all conditions that are replicated in our biorepositories worldwide to ensure accurate, consistent research results.
Consistent specimen collection. With real-time sample processing occurring in over 50 countries on 6 continents, we are able to manage the sample from draw to assay, streamlining handling and ensuring sample preservation, integrity, and consistency.
Clinical immune monitoring. Our comprehensive assessment of immune status and function informs preclinical and clinical trials through postmarket surveillance. We offer one of the broadest arrays of immune monitoring solutions in the industry. Our technology platforms include flow cytometry, ELISpot, NanoString, and multiplexed cytokine assessments that can be implemented consistently at scale. Of note, we offer epigenetic-based immune monitoring through our proprietary offering, Epiontis ID, a rapid, cost-effective technology that delivers robust immune status data.
Explore immune monitoring solutions
Discover Epiontis ID
Tissue profiling and liquid biopsy biomarkers. Precision offers advanced solutions for tissue and liquid biopsy profiling. We can design assays and validate biomarkers for immune-oncology applications including standard immunohistochemistry and multiplex immunofluorescence image analysis. We also offer assays using our proprietary ApoStream® liquid biopsy technology, which can generate both phenotypic and genomic information from the same biopsy sample. ApoStream allows for the capture, enrichment, and subsequent analysis of CTCs and other rare cells without the need for labels or antibodies.
Bioanalytical services for large molecules. Our renowned scientific leadership helped establish the basis of FDA and EMA guidance in immunogenicity. Our passions include assays for PEGylated proteins, ADCs, bispecifics, gene therapies, CAR-T’s novel techniques such as drug-specific IgE assays, and assessments of complement activation.